Theravance Bio stock falls 6% after nezulcitinib flunks mid-stage COVID-19 induced lung injury study
June 21 2021 - 7:13AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Theravance Biopharma (NASDAQ:TBPH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Theravance Biopharma (NASDAQ:TBPH)
Historical Stock Chart
From Sep 2023 to Sep 2024